Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 9/25/13  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Achim Knappik

Wrong Dr. Achim Knappik?

Senior Director , Head of R and D

Local Address: Germany
AbD Serotec Ltd
Endeavour House, Langford Business ParkLangford Lane, Kidlington,
Oxford, Oxfordshire OX5 1GF
United Kingdom

Company Description: AbD Serotec, a division of MorphoSys, now provides users with a single source for more than 10,000 high quality antibodies from the combined ranges of Serotec,...   more
Background

Employment History

  • Head of Research and Development
    AbD Serotec Ltd
  • Senior Director of Research and Development
    Antibodies

Education

  • PhD
26 Total References
Web References
Der Industrie mangelt es an ...
www.oem.abdserotec.com, 13 June 2011 [cached]
Der Industrie mangelt es an Antigen-spezifischen, vollständig menschlichen und insbesondere monoklonalenAntikörper eines bestimmten Isotyps in reproduzierbarer Qualität - alles Anforderungen, die unsere HuCAL-Technologie perfekt erfüllen kann", erklärt Dr. Achim Knappik, Head of R&D, AbD Serotec.
AbD Serotec > About Us > News Releases
www.a-by-d.com, 15 May 2006 [cached]
"Proteomic studies require the rapid generation of specific and high-affinity antibodies against a large number of proteins that are present usually only in sub-mg quantities - something that is difficult to achieve with traditional immunization strategies," comments Dr. Achim Knappik, Senior Director of R&D at Antibodies by Design.
Dr Achim Knappik of AbD ...
www.abdserotec.com, 29 Sept 2010 [cached]
Dr Achim Knappik of AbD Serotec describes the use of recombinant anti-idiotypic antibodies as specialized tools in the development of preclinical and clinical research assays for antibody drug development and how they are generated using proprietary HuCAL® recombinant antibody generation technology.
AbD Serotec News Releases - AbD Serotec
www.abdserotec.com, 29 Sept 2010 [cached]
Der Industrie mangelt es an Antigen-spezifischen, vollständig menschlichen und insbesondere monoklonalenAntikörper eines bestimmten Isotyps in reproduzierbarer Qualität - alles Anforderungen, die unsere HuCAL-Technologie perfekt erfüllen kann", erklärt Dr. Achim Knappik, Head of R&D, AbD Serotec.
Dr. Achim Knappik, Head of ...
www.biospace.com, 23 Sept 2008 [cached]
Dr. Achim Knappik, Head of R&D at AbD Serotec commented, "Today's news further exemplifies the unique flexibility of our HuCAL antibody platform and the broad range of potential applications which we can target. e2v's approach to establish a novel type of point of care system is highly innovative and very interesting both scientifically and commercially.
Other People with the name "Knappik":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304